VBI Vaccines Receives US FDA Orphan Drug Designation for VBI-1901 for the Treatment of Glioblastoma
VBI Vaccines Inc. announced that the US FDA granted Orphan Drug Designation for VBI-1901, a bivalent gB/pp65 immunotherapeutic vaccine candidate for the treatment of glioblastoma.
[Oncology Reports] The expression profiles of circRNAs and mRNAs were compared between gastric cancer‑MSCs and bone marrow‑derived MSCs using microarray analysis.
[Journal Of Clinical Pathology] Scientists evaluated the association between perilipin 1 or adipophilin expression and prognosis in liposarcoma. 97 primary resection specimens were examined.